EUPRAXIA PHARMACEUTICALS INC.
For the period ended Dec 31, 2024. Filed Mar 20, 2025.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2024 · Filed Mar 20, 2025
Use the contents to explore the available documents and sections.
EPRX$6.89+4.4%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Facilities
Facilities
Our head office is located in Victoria, British Columbia, Canada. The nature of the space is immaterial to our operations as operating activities related to our pipeline product candidates are primarily outsourced to contractors.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.